FOCUS Investment Banking Represents The Retina Eye Center in its Sale to Retina Consultants of America
Washington, DC, (August 17, 2022) – FOCUS Investment Banking (“FOCUS”), a ...
FOCUS Investment Banking Represents Lee Eye Center in its Sale to Midwest Vision Partners
Washington, DC, (August 4, 2022) – FOCUS Investment Banking (“FOCUS”), a ...
Private Equity’s Interest in Interventional Pain Management Practices
Private equity investors are becoming increasingly interested in interventional pain management practices.
Cardiology May be The Next Big Thing in Physician Practice Management
Investor interest in cardiovascular services is growing, and doctors sense an opportunity.
Urology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered three reported urology practice acquisitions, continuing a pattern of smaller deal volume and larger deal size when compared to other practice specialties undergoing M&A consolidation.
Orthopedics – Q1 2022 Acquisition Activity and Outlook
The 1st quarter of 2022 delivered nine reported orthopedic practice acquisitions, continuing the trend of increasing deal volume.
Ophthalmology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered eleven reported ophthalmology practice acquisitions, marking a sharp decline from the flurry of closings at the end of last year This was expected as business development teams had exhausted all resources toward closing deals last quarter We will highlight a few notable deals.
Home Health & Hospice – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered twenty-eight reported home health and hospice acquisitions, coming down from peaks levels to end the past year However, Q1 has historically brought lower M&A levels, and we expect deal volume to rebound throughout the year.
Gastroenterology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered ten reported gastroenterology practice acquisitions, continuing the high level of M&A activity we saw last year Several deals were announced in the first few weeks of the year, likely spilling over from efforts to close in 2021.
ENT & Allergy – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.
